100 related articles for article (PubMed ID: 6245002)
1. Concentration and purification of poliovirus by immune adsorption on immobilized antibodies.
van der Marel P; van Wezel AL; Hazendonk AG; Kooistra A
Dev Biol Stand; 1980; 46():267-73. PubMed ID: 6245002
[TBL] [Abstract][Full Text] [Related]
2. Intratypic differentiation of poliovirus strains by enzyme-linked immunosorbent assay (ELISA): poliovirus type 1.
Glikmann G; Moynihan M; Petersen I; Vestergaard BF
Dev Biol Stand; 1983; 55():199-208. PubMed ID: 6203794
[TBL] [Abstract][Full Text] [Related]
3. Enzyme-linked immunosorbent assay for detection of poliovirus antigen and antibody.
Moynihan M; Ladefoged P; Mathiesen L
Dev Biol Stand; 1980; 46():203-6. PubMed ID: 6244998
[TBL] [Abstract][Full Text] [Related]
4. Large-scale concentration and purification of virus suspension from microcarrier culture for the preparation of inactivated virus vaccines.
van Wezel AL; van Herwaarden JA; van de Heuvel-de Rijk EW
Dev Biol Stand; 1979; 42():65-9. PubMed ID: 223923
[TBL] [Abstract][Full Text] [Related]
5. Decision analysis in planning for a polio outbreak in the United States.
Jenkins PC; Modlin JF
Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
[TBL] [Abstract][Full Text] [Related]
6. Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains.
Tano Y; Shimizu H; Martin J; Nishimura Y; Simizu B; Miyamura T
Vaccine; 2007 Oct; 25(41):7041-6. PubMed ID: 17825459
[TBL] [Abstract][Full Text] [Related]
7. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.
Herremans TM; Reimerink JH; Buisman AM; Kimman TG; Koopmans MP
J Immunol; 1999 Apr; 162(8):5011-8. PubMed ID: 10202050
[TBL] [Abstract][Full Text] [Related]
8. Parameters for differentiating vaccine-derived and wild poliovirus strains.
Nakano JH; Hatch MH; Thieme ML; Nottay B
Prog Med Virol; 1978; 24():178-206. PubMed ID: 212784
[No Abstract] [Full Text] [Related]
9. Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method.
Rezapkin G; Martin J; Chumakov K
Biologicals; 2005 Mar; 33(1):29-39. PubMed ID: 15713554
[TBL] [Abstract][Full Text] [Related]
10. Direct enzyme linked immunosorbent assay (ELISA) for quantification of poliomyelitis virus D-antigen.
Souvras M; Montagnon B; Fanget B; van Wezel AL; Hazendonk AG
Dev Biol Stand; 1980; 46():197-202. PubMed ID: 6244997
[TBL] [Abstract][Full Text] [Related]
11. Improved ELISA test for determination of potency of Inactivated Poliovirus Vaccine (IPV).
Rezapkin G; Dragunsky E; Chumakov K
Biologicals; 2005 Mar; 33(1):17-27. PubMed ID: 15713553
[TBL] [Abstract][Full Text] [Related]
12. D-antigen determination in polio vaccine production: comparison of gel diffusion and ELISA methods.
van der Marel P; Hazendonk AG; van Wezel AL
Dev Biol Stand; 1981; 47():101-8. PubMed ID: 6262140
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
Sawyer LA; McInnis J; Albrecht P
Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.
Dragunsky EM; Ivanov AP; Wells VR; Ivshina AV; Rezapkin GV; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
J Infect Dis; 2004 Oct; 190(8):1404-12. PubMed ID: 15378432
[TBL] [Abstract][Full Text] [Related]
15. Progress with inactivated poliovirus vaccines derived from the Sabin strains.
Doi Y; Abe S; Yamamoto H; Horie H; Ohyama H; Satoh K; Tano Y; Ota Y; Miyazawa M; Wakabayashi K; Hashizume S
Dev Biol (Basel); 2001; 105():163-9. PubMed ID: 11763324
[TBL] [Abstract][Full Text] [Related]
16. Use of elution marker for the intratypic characterization of poliovirus strains.
Szöllõsy E; Mucsi I; Pálmai M
Acta Microbiol Acad Sci Hung; 1976; 23(4):301-8. PubMed ID: 193364
[TBL] [Abstract][Full Text] [Related]
17. Current advances in viral diagnostic technology applicable to polio vaccination and diagnosis.
Chernesky MA
Rev Infect Dis; 1984; 6 Suppl 2():S525-7. PubMed ID: 6330851
[TBL] [Abstract][Full Text] [Related]
18. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
[TBL] [Abstract][Full Text] [Related]
19. Immunity status to polioviruses among non-European union immigrants in Veneto Region (North-East Italy).
Trivello R; Ngatchu T; Marin V; Moretti G; Malatesta R; Maini P; Moschen ME; Baldo V; De Marzi L; Majori S; Puppo A; Renzulli G
Ann Clin Lab Sci; 1996; 26(2):154-9. PubMed ID: 8852425
[TBL] [Abstract][Full Text] [Related]
20. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.
Yang C; Shi H; Zhou J; Liang Y; Xu H
Vaccine; 2009 Nov; 27(47):6558-63. PubMed ID: 19729087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
